These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 29380823

  • 1. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED, Kim HM, Schoenfeld P.
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
    Miner PB.
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):71-84. PubMed ID: 31985305
    [Abstract] [Full Text] [Related]

  • 4. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y, Fang J, Guo X, Dai N, Shen X, Yang Y, Sun J, Bhandari BR, Reasner DS, Cronin JA, Currie MG, Johnston JM, Zeng P, Montreewasuwat N, Chen GZ, Lim S.
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation.
    Cash BD, Sharma A, Walker A, Laitman AP, Chang L.
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14632. PubMed ID: 37332239
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Schoenfeld P, Lacy BE, Chey WD, Lembo AJ, Kurtz CB, Reasner DS, Bochenek W, Tripp K, Currie MG, Fox SM, Blakesley RE, OʼDea CR, Omniewski ND, Hall ML.
    Am J Gastroenterol; 2018 Jan; 113(1):105-114. PubMed ID: 29091082
    [Abstract] [Full Text] [Related]

  • 9. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ, Cheng V, Cremonini F.
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan.
    Fukudo S, Miwa H, Nakajima A, Haruma K, Kosako M, Nakagawa A, Akiho H, Yamaguchi Y, Johnston JM, Currie M, Kinoshita Y.
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13444. PubMed ID: 30136447
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
    Waldman SA, Tenenbaum R, Foehl HC, Winkle P, Griffin P.
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00016. PubMed ID: 31318728
    [Abstract] [Full Text] [Related]

  • 15. Effects of linaclotide in the treatment of chronic constipation and irritable bowel syndrome with constipation: a meta-analysis.
    Zhao Q, Fang Y, Yan C, Gao J, Liu Z, Zhu H, Tang D, Wang D.
    Z Gastroenterol; 2022 Jun; 60(6):970-977. PubMed ID: 34215016
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
    Brenner DM, Fogel R, Dorn SD, Krause R, Eng P, Kirshoff R, Nguyen A, Crozier RA, Magnus L, Griffin PH.
    Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older.
    Menees SB, Franklin H, Chey WD.
    Clin Ther; 2020 Jul; 42(7):1406-1414.e4. PubMed ID: 32660770
    [Abstract] [Full Text] [Related]

  • 20. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
    Love BL, Johnson A, Smith LS.
    Am J Health Syst Pharm; 2014 Jul 01; 71(13):1081-91. PubMed ID: 24939497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.